WuXi Biologics
A 24-month rotational leadership program designed to develop future Quality Control leadership through diverse assignments across US and China operations. Participants will rotate through various functions including physiochemistry, bioassay, microbiology, operations support, and analytical sciences to gain comprehensive technical expertise.
A leading global open-access biologics technology platform offering end-to-end solutions to empower organizations to discover, develop and manufacture biologics from concept to commercial manufacturing
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for WuXi Biologics.